Clinical Trial Update: Prognostic Factors for Patients With Advanced Colorectal Cancer Treated With Cetuximab. [Phase 2]

View source ↗

Summary

This clinical trial update reports on prognostic factors for patients with advanced colorectal cancer treated with cetuximab in a Phase 2 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Regione Lombardia | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED